Maurilio J. Soares
Carlos Chagas Institute/Fiocruz PR
Curitiba, PR, Brazil
Curitiba, PR, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
In Silico, In Vitro, and Pharmacokinetic Studies of UBMC-4, a Potential Novel Compound for Treating against Trypanosoma cruzi.
Journal: Pathogens (Basel, Switzerland)
Published: April 24, 2022
Biocompatible gum arabic-gold nanorod composite as an effective therapy for mistreated melanomas.
Journal: International journal of biological macromolecules
Published: March 30, 2021
Beyond gold nanoparticles cytotoxicity: Potential to impair metastasis hallmarks.
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: May 07, 2020
The terpenic diamine GIB24 inhibits the growth of Trypanosoma cruzi epimastigotes and intracellular amastigotes, with proteomic analysis of drug-resistant epimastigotes.
Journal: Chemico-biological interactions
Published: April 10, 2020
Toxicological Aspects of the Essential Oil from Cinnamodendron dinisii.
Journal: Chemistry & biodiversity
Published: February 19, 2018
Subcellular localisation of FLAG tagged enzymes of the dynamic protein S-palmitoylation cycle of Trypanosoma cruzi epimastigotes.
Journal: Memorias do Instituto Oswaldo Cruz
Published: February 16, 2018
Synthesis of novel quinine analogs and evaluation of their effects on Trypanosoma cruzi.
Journal: Future medicinal chemistry
Published: January 31, 2018
Occurrence of hemotropic mycoplasmas in non-human primates (Alouatta caraya, Sapajus nigritus and Callithrix jacchus) of southern Brazil.
Journal: Comparative immunology, microbiology and infectious diseases
Published: November 22, 2016
The Akt-like kinase of Leishmania panamensis: As a new molecular target for drug discovery.
Journal: Acta tropica
Published: October 11, 2016
Last Updated: 09/26/2026